Using focus groups to identify barriers to drug use in patients with congestive heart failure

Pharmacotherapy

Volumn 20, Issue 7 I, 2000, Pages 823-829

  Simpson, Scot H ^c   Farris, Karen B ^a   Johnson, Jeffrey A ^a   Tsuyuki, Ross T ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DAILY LIFE ACTIVITY; DIURETIC THERAPY; DRUG COST; FEMALE; GROUP THERAPY; HEALTH CARE PERSONNEL; HUMAN; INTERPERSONAL COMMUNICATION; MALE; PATIENT COMPLIANCE; PATIENT INFORMATION; SOCIAL SUPPORT; TREATMENT PLANNING;

EID: 0033922587     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.9.823.35205     Document Type: Article

References (41)

1. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997;45:968-74.
2. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993;88: 107-115.
3. Gheorghiade M, Benatar D, Konstam MA, Stoukides CA, Bonow RO. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials. Am J Cardiol 1997;80:14H-27.
4. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. Arch Intern Med 1996;156:1669-73.
5. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance Ann Intern Med 1984;100: 258-68.
6. Sackett DL. The magnitude of compliance and noncompliance. In: Sackett DL, Haynes RB, eds. Compliance with therapeutic regimens. Baltimore, London: Johns Hopkins University Press, 1976:1-25.
7. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;154:433-7.
8. Houston Miller N, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for health care professionals. Circulation 1997;95: 1085-90.
9. Berg JS, Dishler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Patient compliance. Ann Pharmacother 1993;27(suppl):S5-19.
10. McDermott MM, Schmitt B, Wallner E. Impact of drug nonadherence on coronary heart disease outcomes. Arch Intern Med 1997;157:1921-9.
11. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with drug regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharmaceut Economics 1990;2:1933.
12. Coambs RB, Jensen P, Her MH, et al. Review of the scientific literature on the prevalence, consequences, and health costs of noncompliance & inappropriate use of prescription drug in Canada. Ottawa: Pharmaceutical Manufacturers Association of Canada, 1995.
13. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-5.
14. Wagdi P, Vuilliomemet A, Kaufmann U, Richter M, Bertel O. Inadequate compliance, patient information and drug prescription as causes of emergency hospitalization of chronic heart failure patients. Schweiz Med Wochenschr 1993;123:108-12.
15. Feenstra J, Grobbee DE, Jonkman FA, Hoes AW, Stricker BH. Prevention of relapse in patients with congestive heart failure: the role of precipitating factors. Heart 1998;80:432-6.
16. Lasagna L, Hutt PB. Health care, research, and regulatory impact of noncompliance. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991:393-403.
17. Strömberg A, Broström A, Dahlström U, Fridlund B. Factors influencing patient compliance with therapeutic regimens in chronic heart failure: a critical incident technique analysis. Heart Lung 1999;28:334-41.
18. Goodyer L, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract 1995;49:173-6.
19. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on drug compliance in elderly patients with congestive heart failure. Am J Med 1996;101:270-6.
20. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999;19:860-9.
21. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-6.
22. Krueger RA, ed. Focus groups: a practical guide for applied research, 2nd ed. Thousand Oaks, CA: Sage, 1994.
23. Morgan DL, ed. Successful focus groups: advancing the state of the art. Newbury Park, CA: Sage, 1993.
24. Hassell K, Hibbert D. The use of focus groups in pharmacy research: processes and practicalities. J Soc Admin Pharm 1996;13:169-77.
25. Smith F. Focus groups and observation studies. Int J Pharm Pract 1998;6:229-42.
26. Fallsberg M. Medication compliance in real life. Drug Information J 1994;28:565-9.
27. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 1995;11:443-55.
28. Diamond WD, Gagnon JP. Obtaining pharmacy class feedback through the use of focus group interviews. Am J Pharm Educ 1985;49:49-54.
29. Reutzel TJ, DeFalco PG, Hogan M, Kazerooni PV. Evaluation of a pharmaceutical care education series for chain pharmacists using the focus group method. J Am Pharm Assoc 1999;39:226-34.
30. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott-Raven, 1996:49-50.
31. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med 1999;159:1939-45.
32. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of drug adherence. Med Care 1986;24:67-74.
33. Miles MB, Huberman AM, eds. Qualitative data analysis: an expanded sourcebook, 2nd ed. Thousand Oaks, CA: Sage, 1994.
34. McAlister FA, Teo KK, Taher M, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999;138:87-94.
35. Michalsen A, König G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998;80:437-41.
36. Bennett SJ, Milgrom LB, Champion V, Huster GA. Beliefs about drug and dietary compliance in people with heart failure: an instrument development study. Heart Lung 1997;26:273-9.
37. Falvo DR. Effective patient education: a guide to increased compliance. Gaithersburg, MD: Aspen, 1994.
38. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the medical outcomes study. J Behav Med 1992;15:447-68.
39. Ajzen I, Fishhein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ; Prentice-Hall, 1980.
40. Conrad P. The meaning of drugs: another look at compliance. Soc Sci Med 1985;20:29-37.
41. Weintraub M. A different view of patient compliance in the elderly. In: Vestal RE, ed. Drug treatment in the elderly. Sydney: ADIS Health Science Press, 1984.